HEADER BIOSYNTHETIC PROTEIN, LIGASE 26-FEB-21 7LVP TITLE CRYPTOCOCCUS NEOFORMANS AIR SYNTHETASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: AIR SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE,PHOSPHORIBOSYL- COMPND 5 AMINOIMIDAZOLE SYNTHETASE,PHOSPHORIBOSYLAMINE--GLYCINE LIGASE, COMPND 6 PHOSPHORIBOSYLFORMYLGLYCINAMIDINE CYCLO-LIGASE, COMPND 7 PHOSPHORIBOSYLGLYCINAMIDE SYNTHETASE; COMPND 8 EC: 6.3.3.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRYPTOCOCCUS NEOFORMANS VAR. GRUBII SEROTYPE A; SOURCE 3 ORGANISM_COMMON: FILOBASIDIELLA NEOFORMANS VAR. GRUBII; SOURCE 4 ORGANISM_TAXID: 235443; SOURCE 5 STRAIN: H99 / ATCC 208821 / CBS 10515 / FGSC 9487; SOURCE 6 GENE: CNAG_06314; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS AIR SYNTHETASE, PHOSPHORIBOSYL-AMINOIMIDAZOLE SYNTHETASE, KEYWDS 2 PHOSPHORIBOSYLAMINOIMIDAZOLE SYNTHETASE, BIOSYNTHETIC PROTEIN, KEYWDS 3 LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR S.M.H.CHUA,Z.LUO,B.Y.J.LIM,B.KOBE,J.A.FRASER REVDAT 4 18-OCT-23 7LVP 1 REMARK REVDAT 3 29-SEP-21 7LVP 1 JRNL REVDAT 2 01-SEP-21 7LVP 1 JRNL REVDAT 1 25-AUG-21 7LVP 0 JRNL AUTH S.M.H.CHUA,M.S.I.WIZRAH,Z.LUO,B.Y.J.LIM,U.KAPPLER,B.KOBE, JRNL AUTH 2 J.A.FRASER JRNL TITL STRUCTURAL FEATURES OF CRYPTOCOCCUS NEOFORMANS BIFUNCTIONAL JRNL TITL 2 GAR/AIR SYNTHETASE MAY PRESENT NOVEL ANTIFUNGAL DRUG JRNL TITL 3 TARGETS. JRNL REF J.BIOL.CHEM. V. 297 01091 2021 JRNL REFN ESSN 1083-351X JRNL PMID 34416230 JRNL DOI 10.1016/J.JBC.2021.101091 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 12869 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.290 REMARK 3 FREE R VALUE TEST SET COUNT : 552 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.8800 - 3.5500 1.00 3117 149 0.1785 0.2222 REMARK 3 2 3.5500 - 2.8200 1.00 3094 134 0.2084 0.2385 REMARK 3 3 2.8200 - 2.4600 1.00 3070 134 0.2150 0.2444 REMARK 3 4 2.4600 - 2.2400 0.99 3036 135 0.2373 0.3036 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.927 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.95 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2167 REMARK 3 ANGLE : 0.421 2930 REMARK 3 CHIRALITY : 0.042 344 REMARK 3 PLANARITY : 0.003 370 REMARK 3 DIHEDRAL : 9.633 773 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LVP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1000255075. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-AUG-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12876 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.240 REMARK 200 RESOLUTION RANGE LOW (A) : 42.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 0.1480 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.69300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.026 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5VK4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SPG (SUCCINIC ACID, SODIUM REMARK 280 DIHYDROGEN PHOSPHATE, AND GLYCINE IN RATIO OF 2:7:7), 25% W/V REMARK 280 PEG1500, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 42.65000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.88450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 42.65000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 42.88450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 83.10621 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 74.00349 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 532 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 HIS A 2 REMARK 465 HIS A 3 REMARK 465 HIS A 4 REMARK 465 HIS A 5 REMARK 465 HIS A 6 REMARK 465 HIS A 7 REMARK 465 SER A 8 REMARK 465 SER A 9 REMARK 465 GLY A 10 REMARK 465 VAL A 11 REMARK 465 ASP A 12 REMARK 465 LEU A 13 REMARK 465 GLY A 14 REMARK 465 THR A 15 REMARK 465 GLU A 16 REMARK 465 ASN A 17 REMARK 465 LEU A 18 REMARK 465 TYR A 19 REMARK 465 PHE A 20 REMARK 465 GLN A 21 REMARK 465 SER A 22 REMARK 465 ASN A 23 REMARK 465 ALA A 24 REMARK 465 MET A 25 REMARK 465 GLY A 26 REMARK 465 PHE A 27 REMARK 465 TYR A 91 REMARK 465 TYR A 92 REMARK 465 ALA A 93 REMARK 465 CYS A 94 REMARK 465 SER A 95 REMARK 465 LYS A 96 REMARK 465 LEU A 97 REMARK 465 ASP A 98 REMARK 465 GLY A 122 REMARK 465 GLY A 123 REMARK 465 GLU A 124 REMARK 465 THR A 125 REMARK 465 ALA A 126 REMARK 465 GLU A 127 REMARK 465 MET A 128 REMARK 465 PRO A 129 REMARK 465 GLY A 130 REMARK 465 MET A 131 REMARK 465 TYR A 132 REMARK 465 HIS A 133 REMARK 465 GLY A 134 REMARK 465 ASP A 135 REMARK 465 ASP A 136 REMARK 465 TYR A 137 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 50 -72.76 -105.52 REMARK 500 HIS A 173 -109.70 54.91 REMARK 500 THR A 234 -124.85 -116.10 REMARK 500 THR A 284 -49.11 -132.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7LVO RELATED DB: PDB REMARK 900 7LVO AND 7LVP ARE BOTH COMPONENTS OF THE BIFUNCTIONAL GAR REMARK 900 SYNTHETASE/AIR SYNTHETASE DBREF 7LVP A 26 336 UNP J9VYP5 J9VYP5_CRYNH 492 802 SEQADV 7LVP MET A 1 UNP J9VYP5 INITIATING METHIONINE SEQADV 7LVP HIS A 2 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP HIS A 3 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP HIS A 4 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP HIS A 5 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP HIS A 6 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP HIS A 7 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP SER A 8 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP SER A 9 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP GLY A 10 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP VAL A 11 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP ASP A 12 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP LEU A 13 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP GLY A 14 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP THR A 15 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP GLU A 16 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP ASN A 17 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP LEU A 18 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP TYR A 19 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP PHE A 20 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP GLN A 21 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP SER A 22 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP ASN A 23 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP ALA A 24 UNP J9VYP5 EXPRESSION TAG SEQADV 7LVP MET A 25 UNP J9VYP5 EXPRESSION TAG SEQRES 1 A 336 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 336 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA MET GLY SEQRES 3 A 336 PHE GLY GLY ALA PHE ASP LEU ALA LYS ALA GLY TYR LYS SEQRES 4 A 336 ASP PRO ILE LEU VAL SER GLY THR ASP GLY VAL GLY THR SEQRES 5 A 336 LYS LEU ARG VAL ALA LEU ASP HIS GLY LYS HIS ASN THR SEQRES 6 A 336 VAL GLY ILE ASP LEU VAL ALA MET SER VAL ASN ASP LEU SEQRES 7 A 336 ILE VAL GLN GLY ALA GLU PRO LEU TYR PHE LEU ASP TYR SEQRES 8 A 336 TYR ALA CYS SER LYS LEU ASP VAL PRO VAL ALA ALA ASP SEQRES 9 A 336 VAL ILE THR GLY ILE ALA GLU GLY CYS LEU GLN ALA GLY SEQRES 10 A 336 CYS ALA LEU ILE GLY GLY GLU THR ALA GLU MET PRO GLY SEQRES 11 A 336 MET TYR HIS GLY ASP ASP TYR ASP LEU ALA GLY PHE ALA SEQRES 12 A 336 VAL GLY VAL VAL GLU ARG ALA GLN ILE LEU PRO THR PRO SEQRES 13 A 336 ASP ILE ALA SER GLY ASP VAL LEU LEU ALA LEU SER SER SEQRES 14 A 336 SER GLY PRO HIS SER ASN GLY PHE SER LEU ILE ARG LYS SEQRES 15 A 336 ILE VAL SER LEU SER ASN LEU SER LEU HIS ASP THR ALA SEQRES 16 A 336 PRO TRP ASP LYS ASN THR SER VAL GLY ASP ALA LEU LEU SEQRES 17 A 336 THR PRO THR LYS VAL TYR ILE LYS PRO LEU LEU PRO GLY SEQRES 18 A 336 ILE LYS SER GLY LEU TYR LYS GLY MET SER HIS ILE THR SEQRES 19 A 336 GLY GLY GLY PHE THR GLU ASN ILE PRO ARG ILE PHE SER SEQRES 20 A 336 SER ALA SER ASN LEU GLY VAL LYS LEU ASP LEU THR SER SEQRES 21 A 336 TYR SER LEU PRO ALA ILE TRP LYS TRP LEU MET ARG ALA SEQRES 22 A 336 GLY ASN VAL GLU ALA LYS GLU MET VAL ARG THR PHE ASN SEQRES 23 A 336 CYS GLY VAL GLY MET ILE ILE ILE VAL ALA LYS ASP LYS SEQRES 24 A 336 ALA ASP ALA ALA LEU SER SER LEU LYS GLU ASN GLY GLU SEQRES 25 A 336 GLU ALA TRP VAL ILE GLY GLU VAL GLN GLU LYS LYS GLY SEQRES 26 A 336 VAL GLU TYR VAL GLY LEU ASP LYS PHE GLY LEU HET EDO A 401 10 HET EDO A 402 10 HET SIN A 403 12 HET PO4 A 404 5 HET PO4 A 405 5 HET GLY A 406 10 HET EDO A 407 10 HETNAM EDO 1,2-ETHANEDIOL HETNAM SIN SUCCINIC ACID HETNAM PO4 PHOSPHATE ION HETNAM GLY GLYCINE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 EDO 3(C2 H6 O2) FORMUL 4 SIN C4 H6 O4 FORMUL 5 PO4 2(O4 P 3-) FORMUL 7 GLY C2 H5 N O2 FORMUL 9 HOH *62(H2 O) HELIX 1 AA1 GLY A 51 GLY A 61 1 11 HELIX 2 AA2 HIS A 63 VAL A 80 1 18 HELIX 3 AA3 PRO A 100 GLY A 117 1 18 HELIX 4 AA4 ALA A 150 ILE A 152 5 3 HELIX 5 AA5 GLY A 176 SER A 187 1 12 HELIX 6 AA6 SER A 202 THR A 209 1 8 HELIX 7 AA7 TYR A 214 SER A 224 1 11 HELIX 8 AA8 GLY A 236 ILE A 242 1 7 HELIX 9 AA9 PRO A 243 PHE A 246 5 4 HELIX 10 AB1 PRO A 264 GLY A 274 1 11 HELIX 11 AB2 GLU A 277 VAL A 282 1 6 HELIX 12 AB3 ALA A 296 ASP A 298 5 3 HELIX 13 AB4 LYS A 299 ASN A 310 1 12 SHEET 1 AA1 4 PRO A 41 GLY A 49 0 SHEET 2 AA1 4 ALA A 140 GLU A 148 -1 O GLY A 141 N ASP A 48 SHEET 3 AA1 4 GLU A 84 LEU A 89 -1 N LEU A 86 O VAL A 144 SHEET 4 AA1 4 ALA A 119 LEU A 120 1 O ALA A 119 N LEU A 86 SHEET 1 AA2 6 GLY A 229 HIS A 232 0 SHEET 2 AA2 6 VAL A 289 VAL A 295 -1 O ILE A 294 N GLY A 229 SHEET 3 AA2 6 VAL A 163 SER A 168 -1 N LEU A 165 O ILE A 293 SHEET 4 AA2 6 ALA A 314 GLN A 321 -1 O TRP A 315 N ALA A 166 SHEET 5 AA2 6 GLY A 253 ASP A 257 -1 N ASP A 257 O ILE A 317 SHEET 6 AA2 6 VAL A 326 VAL A 329 1 O GLU A 327 N LEU A 256 CISPEP 1 LEU A 153 PRO A 154 0 -1.55 CRYST1 85.300 85.769 37.018 90.00 91.70 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011723 0.000000 0.000348 0.00000 SCALE2 0.000000 0.011659 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027026 0.00000